Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseBone Marrow TransplantationTransplantation, AutologousTransplantation ConditioningHematologic NeoplasmsHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorGraft SurvivalTransplantation ChimeraTissue DonorsBusulfanAntigens, CD34Immunosuppressive AgentsLeukapheresisTreatment OutcomeBone MarrowVidarabineRecurrenceBone Marrow CellsHematopoietic Stem CellsLeukemiaHistocompatibilityStem CellsWhole-Body IrradiationHistocompatibility TestingGraft vs Leukemia EffectBlood Component RemovalStem Cell TransplantationRetrospective StudiesSurvival AnalysisMyeloablative AgonistsCombined Modality TherapyCyclophosphamideMelphalanChronic DiseaseCytomegalovirus InfectionsMultiple MyelomaAnemia, AplasticAntineoplastic Combined Chemotherapy ProtocolsPrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalT-LymphocytesBlood CellsBone and BonesHLA AntigensLymphoma, Non-HodgkinTime FactorsBone Marrow PurgingOpportunistic InfectionsHematopoiesisCord Blood Stem Cell TransplantationImmunocompromised HostCyclosporineRemission InductionLeukemia, Myeloid, AcuteBone Marrow DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Cell CountHematologic DiseasesTransplantation, IsogeneicImmunosuppressionSurvival RateInfectionEtoposideLymphocyte DepletionTransplantationCytomegalovirusThiotepaFatal OutcomeAcute DiseaseTransplantation ImmunologyFlow CytometryBlood DonorsSalvage TherapyAntineoplastic Agents, AlkylatingHodgkin DiseaseLymphocyte TransfusionLeukocyte TransfusionMyelodysplastic SyndromesMycosesColony-Forming Units AssayCell SeparationKidney TransplantationGraft RejectionRecombinant ProteinsCell DifferentiationLeukocyte CountFollow-Up StudiesGanciclovirCells, CulturedImmunophenotypingLymphomaNeoplasmsBlood Group IncompatibilityPlatelet CountNuclear FamilyProspective Studies